Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase-Reference-Cited by-同舟云学术

Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase

Published:2022-07-22 Issue:9 Volume:13 Page:1477-1484
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Jung Eunkyung¹,Soto-Acosta Ruben¹,Xie Jiashu¹,Wilson Daniel J.¹,Dreis Christine D.¹,Majima Ryuichi¹^ORCID,Edwards Tiffany C.¹,Geraghty Robert J.¹^ORCID,Chen Liqiang¹^ORCID

Affiliation:

1. Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States

Funder

University of Minnesota

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.2c00265

Reference36 articles.

1. The emergence, genomic diversity and global spread of SARS-CoV-2

2. Molecular Insights into Small‐Molecule Drug Discovery for SARS‐CoV‐2

3. The recent outbreaks of human coronaviruses: A medicinal chemistry perspective

4. Remdesivir: First Approval

5. Molnupiravir: First Approval

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure of SARS-CoV-2 MTase nsp14 with the inhibitor STM957 reveals inhibition mechanism that is shared with a poxviral MTase VP39;Journal of Structural Biology: X;2024-12

2. How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents;European Journal of Medicinal Chemistry;2024-11

3. Click—ferrocenyl nucleotides—synthesis, electrochemistry, and antiproliferative activity studies;Journal of Organometallic Chemistry;2024-08

4. SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug discovery;2024-07-17

5. SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug discovery;2024-07-17